Allscripts Healthcare Solutions Stock Price, News & Analysis (NASDAQ:MDRX)

$14.65 0.49 (3.46 %)
(As of 12/15/2017 04:00 PM ET)
Previous Close$14.15
Today's Range$14.05 - $15.20
52-Week Range$10.19 - $15.20
Volume11.20 million shs
Average Volume2.38 million shs
Market Capitalization$2.60 billion
P/E Ratio33.51
Dividend YieldN/A
Beta1.34

About Allscripts Healthcare Solutions (NASDAQ:MDRX)

Allscripts Healthcare Solutions logoAllscripts Healthcare Solutions, Inc. (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions. The Population Health segment includes the sale of health management and coordinated care solutions, which focus on hospitals, health systems, other care facilities and accountable care organizations (ACOs). The Netsmart segment provides software and technology solutions to the health and human services industry, which includes behavioral health, addiction treatment, intellectual and developmental disability services, child and family services and public health segments, as well as to post-acute home care organizations.

Receive MDRX News and Ratings via Email

Sign-up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Software & Technology Services
Sub-IndustryHealth Care Technology
SectorMedical
SymbolNASDAQ:MDRX
CUSIP01988P10
Phone312-506-1200

Debt

Debt-to-Equity Ratio1.20%
Current Ratio0.98%
Quick Ratio0.98%

Price-To-Earnings

Trailing P/E Ratio33.51
Forward P/E Ratio31.85
P/E Growth2.56

Sales & Book Value

Annual Sales$1.55 billion
Price / Sales1.71
Cash Flow$1.36 per share
Price / Cash10.77
Book Value$6.88 per share
Price / Book2.13

Profitability

Trailing EPS($1.16)
Net Income$2.88 million
Net Margins-12.23%
Return on Equity6.53%
Return on Assets2.04%

Miscellaneous

Employees7,500
Outstanding Shares180,680,000

Allscripts Healthcare Solutions (NASDAQ:MDRX) Frequently Asked Questions

What is Allscripts Healthcare Solutions' stock symbol?

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

How were Allscripts Healthcare Solutions' earnings last quarter?

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) announced its quarterly earnings results on Thursday, August, 4th. The software maker reported $0.14 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.14. The software maker earned $386.50 million during the quarter, compared to analyst estimates of $403.13 million. Allscripts Healthcare Solutions had a positive return on equity of 6.53% and a negative net margin of 12.23%. Allscripts Healthcare Solutions's quarterly revenue was up 2.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.12 earnings per share. View Allscripts Healthcare Solutions' Earnings History.

When will Allscripts Healthcare Solutions make its next earnings announcement?

Allscripts Healthcare Solutions is scheduled to release their next quarterly earnings announcement on Wednesday, February, 14th 2018. View Earnings Estimates for Allscripts Healthcare Solutions.

Where is Allscripts Healthcare Solutions' stock going? Where will Allscripts Healthcare Solutions' stock price be in 2017?

19 brokers have issued 1-year price objectives for Allscripts Healthcare Solutions' stock. Their predictions range from $12.00 to $17.00. On average, they anticipate Allscripts Healthcare Solutions' share price to reach $15.13 in the next year. View Analyst Ratings for Allscripts Healthcare Solutions.

What are Wall Street analysts saying about Allscripts Healthcare Solutions stock?

Here are some recent quotes from research analysts about Allscripts Healthcare Solutions stock:

  • 1. According to Zacks Investment Research, "Allscripts exited the third quarter on a favorable note. A solid guidance for 2017 and an encouraging long-term outlook are the key highlights of the quarter. Also, the expansion in margin is encouraging. We look forward to the takeover of the hospital and health system business of McKesson Corporation.The company’s solid growth in U.S. Core Solutions and Services, fueled by Sunrise electronic health record (EHR) platform and Allscripts Revenue Cycle Management Services, buoys optimism.On the flipside, Allscripts’ continued reliance on mergers and acquisition activities poses substantial integration risks. Further, intensifying competition is a major dampener. The company’s products have a long sales cycle which involves intensive decision-making at different managerial levels. The company also expects a modest increase in operating expenses to support business growth." (11/8/2017)
  • 2. Cantor Fitzgerald analysts commented, "2Q17 recap. Non-GAAP revenue was $428 million compared to FactSet consensus of $426 million. With Netsmart now mostly annualized, non-GAAP revenue grew 7.8% y/y. Adjusted EPS was $0.15 (in line with our estimate and consensus) vs. $0.14 a year ago. Bookings were impressive and grew to $407 million." (8/14/2017)
  • 3. Maxim Group analysts commented, "1Q17 bookings of $286M, up 13.5% y/y, were below our estimate of $302M and consensus of $298M." (5/5/2017)
  • 4. Citigroup Inc. analysts commented, "We are upgrading MDRX shares to Buy following its recent analyst day. Allscripts provided targets for 2018 - 2020 revenue growth of 6%-8% and EPS growth of 12%-15%, both of which are ahead of our forecasts but approximately in-line with the Street. Allscripts is beginning to show better results as non-recurring revenue has stabilized, recurring revenue grows faster, and the mix continues to shift to recurring revenue, with non EMR solutions seeing faster growth. We believe that if Allscripts can hit these targets investors could see a 20% return on the shares this year from current levels." (3/24/2017)
  • 5. Piper Jaffray Companies analysts commented, "We attended Allscripts' Investor Conference yesterday where management discussed its plan to deliver its FY17 guidance and long term growth targets. We believe 6-8% revenue growth and 12-15% EPS growth are achievable, provided the non-recurring revenue has surpassed its decline, and the Platform as a Service model continues to grow. We are tapering our FY18 EPS estimate to be in line with targets while maintaining our 20x EPS valuation, which brings our PT to $14 from $15. Reiterate Neutral." (3/22/2017)

Who are some of Allscripts Healthcare Solutions' key competitors?

Who are Allscripts Healthcare Solutions' key executives?

Allscripts Healthcare Solutions' management team includes the folowing people:

  • Michael A. Klayko, Independent Chairman of the Board (Age 62)
  • Richard J. Poulton, President (Age 51)
  • Paul M. Black, Chief Executive Officer, Director (Age 59)
  • Dennis M. Olis, Interim Chief Financial Officer, Principal Accounting Officer (Age 54)
  • James R. Hewitt, Executive Vice President, Solutions Development (Age 50)
  • Lisa Khorey, Executive Vice President, Chief Client Delivery Officer (Age 50)
  • Brian P. Farley, Senior Vice President, General Counsel and Corporate Secretary; (Age 47)
  • Mara Glickman Aspinall, Independent Director (Age 54)
  • P. Gregory Garrison, Independent Director (Age 63)
  • Jonathan J. Judge, Independent Director (Age 63)

Who owns Allscripts Healthcare Solutions stock?

Allscripts Healthcare Solutions' stock is owned by many different of retail and institutional investors. Top institutional investors include Iridian Asset Management LLC CT (6.66%), Dimensional Fund Advisors LP (5.26%), Fiduciary Management Inc. WI (3.35%), Fuller & Thaler Asset Management Inc. (2.80%), First Trust Advisors LP (2.55%) and Neuberger Berman Group LLC (2.03%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, James Hewitt, Paul Black and Richard J Poulton. View Institutional Ownership Trends for Allscripts Healthcare Solutions.

Who sold Allscripts Healthcare Solutions stock? Who is selling Allscripts Healthcare Solutions stock?

Allscripts Healthcare Solutions' stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, First Trust Advisors LP, TimesSquare Capital Management LLC, Iridian Asset Management LLC CT, Schwab Charles Investment Management Inc., Royce & Associates LP, Cornerstone Capital Management Holdings LLC. and American Century Companies Inc.. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Brian Farley, James Hewitt, Paul Black and Richard J Poulton. View Insider Buying and Selling for Allscripts Healthcare Solutions.

Who bought Allscripts Healthcare Solutions stock? Who is buying Allscripts Healthcare Solutions stock?

Allscripts Healthcare Solutions' stock was purchased by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Systematic Financial Management LP, Janney Capital Management LLC, Monarch Partners Asset Management LLC, Boston Advisors LLC, Ameriprise Financial Inc., Dimensional Fund Advisors LP and Victory Capital Management Inc.. View Insider Buying and Selling for Allscripts Healthcare Solutions.

How do I buy Allscripts Healthcare Solutions stock?

Shares of Allscripts Healthcare Solutions can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Allscripts Healthcare Solutions' stock price today?

One share of Allscripts Healthcare Solutions stock can currently be purchased for approximately $14.65.

How big of a company is Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions has a market capitalization of $2.60 billion and generates $1.55 billion in revenue each year. The software maker earns $2.88 million in net income (profit) each year or ($1.16) on an earnings per share basis. Allscripts Healthcare Solutions employs 7,500 workers across the globe.

How can I contact Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 312-506-1200 or via email at [email protected]


MarketBeat Community Rating for Allscripts Healthcare Solutions (MDRX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  437 (Vote Outperform)
Underperform Votes:  449 (Vote Underperform)
Total Votes:  886
MarketBeat's community ratings are surveys of what our community members think about Allscripts Healthcare Solutions and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Allscripts Healthcare Solutions (NASDAQ:MDRX) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyHold
Consensus Rating Score: 2.552.552.502.44
Ratings Breakdown: 1 Sell Rating(s)
8 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
8 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
8 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
12 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $15.37$15.37$14.75$14.63
Price Target Upside: 18.77% upside18.77% upside13.03% upside17.28% upside

Allscripts Healthcare Solutions (NASDAQ:MDRX) Consensus Price Target History

Price Target History for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Allscripts Healthcare Solutions (NASDAQ:MDRX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/3/2017SunTrust BanksReiterated RatingBuy$16.00N/AView Rating Details
11/3/2017Maxim GroupReiterated RatingBuy$16.00N/AView Rating Details
11/3/2017Robert W. BairdBoost Price TargetOutperform$16.00 -> $17.00N/AView Rating Details
10/27/2017KeyCorpReiterated RatingHoldN/AView Rating Details
10/3/2017Dougherty & CoReiterated RatingBuy$15.00 -> $16.00LowView Rating Details
9/27/2017Cantor FitzgeraldReiterated RatingBuy$17.00LowView Rating Details
9/19/2017Royal Bank of CanadaInitiated CoverageOutperform -> Outperform$17.00MediumView Rating Details
9/11/2017CowenUpgradeMarket Perform -> Outperform$13.00 -> $16.00HighView Rating Details
8/25/2017Jefferies GroupSet Price TargetBuy$17.00LowView Rating Details
8/7/2017CitigroupBoost Price TargetNeutral$13.00 -> $14.00LowView Rating Details
8/7/2017Morgan StanleyBoost Price TargetUnderweight$11.00 -> $12.00LowView Rating Details
7/21/2017Piper Jaffray CompaniesReiterated RatingHold$14.00LowView Rating Details
6/19/2017Leerink SwannDowngradeOutperform -> Market Perform$15.00 -> $13.00MediumView Rating Details
5/15/2017Bank of AmericaInitiated CoverageNeutral$14.00HighView Rating Details
3/27/2017Wells Fargo & CompanyUpgradeMarket Perform -> OutperformHighView Rating Details
3/24/2017Deutsche BankUpgradeHold -> Buy$12.50 -> $14.00LowView Rating Details
2/17/2017OppenheimerReiterated RatingHoldN/AView Rating Details
1/8/2017FBR & CoReiterated RatingHold$12.00N/AView Rating Details
1/3/2017Canaccord GenuityReiterated RatingBuy$17.00N/AView Rating Details
10/30/2016J P Morgan Chase & CoInitiated CoverageBuy$15.00N/AView Rating Details
10/23/2016ArgusReiterated RatingBuy$19.00N/AView Rating Details
8/5/2016Goldman Sachs GroupBoost Price TargetNeutral$14.00 -> $16.00N/AView Rating Details
2/19/2016BarclaysLower Price TargetEqual Weight$15.00 -> $14.00N/AView Rating Details
1/5/2016Topeka Capital MarketsBoost Price TargetHold$14.00 -> $15.00N/AView Rating Details
1/4/2016Raymond James FinancialDowngradeOutperform -> Market PerformN/AView Rating Details
(Data available from 12/16/2015 forward)

Earnings

Allscripts Healthcare Solutions (NASDAQ:MDRX) Earnings History and Estimates Chart

Earnings by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Allscripts Healthcare Solutions (NASDAQ MDRX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/14/2018$0.19N/AView Earnings Details
8/3/2017Q2 2017$0.15$0.11$424.94 million$426.10 millionViewListenView Earnings Details
5/4/2017Q1 2017$0.09$0.10$415.20 million$415.00 millionViewListenView Earnings Details
2/16/2017Q4 2016$0.15$0.14$424.11 million$425.40 millionViewListenView Earnings Details
11/3/2016Q3$0.15$0.14$414.92 million$392.40 millionViewListenView Earnings Details
8/4/2016Q2$0.14$0.14$403.13 million$386.50 millionViewListenView Earnings Details
5/5/2016Q1$0.12$0.13$348.51 million$346.00 millionViewListenView Earnings Details
2/18/2016Q4$0.13$0.13$357.91 million$345.60 millionViewListenView Earnings Details
11/5/2015Q315$0.12$0.13$354.67 million$355.00 millionViewListenView Earnings Details
8/4/2015Q215$0.11$0.12$347.13 million$351.70 millionViewListenView Earnings Details
5/7/2015Q115$0.09$0.08$344.73 million$335.00 millionViewListenView Earnings Details
2/26/2015Q414$0.09$0.09$358.10 million$343.00 millionViewListenView Earnings Details
11/6/2014Q314$0.10$0.06$353.00 million$348.00 millionViewListenView Earnings Details
8/7/2014Q214$0.09$0.09$353.12 million$351.30 millionViewListenView Earnings Details
5/8/2014Q114$0.07$0.07$347.98 billion$340.30 billionViewListenView Earnings Details
2/20/2014Q413$0.08$0.08$343.47 million$351.00 millionViewListenView Earnings Details
11/7/2013Q313$0.08$0.05$355.30 million$334.00 millionViewListenView Earnings Details
8/8/2013Q2 2013$0.11$0.09$360.00 million$344.80 millionViewListenView Earnings Details
5/9/2013Q1 2013$0.14$0.09$368.11 million$347.10 millionViewListenView Earnings Details
2/19/2013Q4 2012$0.21$0.16$367.07 million$367.70 millionViewListenView Earnings Details
11/8/2012Q312$0.22$0.23$376.97 million$361.00 millionViewN/AView Earnings Details
8/8/2012$0.18$0.16ViewN/AView Earnings Details
4/26/2012$0.24$0.12ViewN/AView Earnings Details
2/16/2012$0.25$0.25ViewN/AView Earnings Details
11/3/2011$0.22$0.25ViewN/AView Earnings Details
8/2/2011$0.21$0.22ViewN/AView Earnings Details
5/5/2011$0.20$0.21ViewN/AView Earnings Details
2/15/2011$0.18$0.20ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Allscripts Healthcare Solutions (NASDAQ:MDRX) Earnings Estimates

2017 EPS Consensus Estimate: $0.47
2018 EPS Consensus Estimate: $0.57
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$0.08$0.11$0.10
Q2 20174$0.10$0.12$0.11
Q3 20175$0.11$0.13$0.12
Q4 20173$0.12$0.15$0.14
Q1 20181$0.13$0.13$0.13
Q2 20181$0.13$0.13$0.13
Q3 20181$0.15$0.15$0.15
Q4 20181$0.16$0.16$0.16
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Allscripts Healthcare Solutions (NASDAQ:MDRX)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Allscripts Healthcare Solutions (NASDAQ MDRX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.75%
Insider Trades by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Allscripts Healthcare Solutions (NASDAQ MDRX) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/1/2017James HewittSVPSell36,796$14.11$519,191.56View SEC Filing  
9/15/2017Richard J. PoultonPresidentSell15,000$13.56$203,400.00View SEC Filing  
9/14/2017Brian FarleyEVPSell5,000$13.52$67,600.00View SEC Filing  
9/14/2017Paul BlackCEOSell15,000$13.52$202,800.00View SEC Filing  
5/16/2017Richard J PoultonPresidentSell25,000$12.06$301,500.00View SEC Filing  
3/23/2017Brian FarleySVPSell15,000$11.63$174,450.00View SEC Filing  
9/15/2016James HewittSVPSell17,500$13.00$227,500.00View SEC Filing  
9/15/2016Paul BlackCEOSell15,000$13.00$195,000.00View SEC Filing  
7/11/2016Dennis OlisSVPSell7,000$14.00$98,000.00View SEC Filing  
7/1/2016James HewittSVPSell17,500$13.00$227,500.00View SEC Filing  
6/13/2016Paul BlackCEOSell15,000$13.04$195,600.00View SEC Filing  
6/13/2016Richard J PoultonPresidentSell10,000$13.03$130,300.00View SEC Filing  
4/7/2016Dennis OlisSVPSell25,000$14.00$350,000.00View SEC Filing  
3/30/2016James HewittSVPSell17,500$13.31$232,925.00View SEC Filing  
3/30/2016Paul BlackCEOSell15,000$13.31$199,650.00View SEC Filing  
3/14/2016Richard J PoultonPresidentSell5,000$12.85$64,250.00View SEC Filing  
8/17/2015James HewittSVPSell70,000$14.17$991,900.00View SEC Filing  
12/12/2014Paul BlackCEOBuy6,500$11.51$74,815.00View SEC Filing  
11/18/2014Anita PramodaDirectorBuy2,017$12.25$24,708.25View SEC Filing  
11/13/2014Dennis ChookaszianDirectorBuy10,000$12.43$124,300.00View SEC Filing  
11/11/2014Dennis OlisSVPBuy4,400$11.26$49,544.00View SEC Filing  
11/11/2014Paul BlackCEOBuy22,180$11.26$249,746.80View SEC Filing  
11/11/2014Richard J PoultonCFOBuy4,500$11.26$50,670.00View SEC Filing  
11/11/2014Stuart L BascombDirectorBuy6,743$11.26$75,926.18View SEC Filing  
8/18/2014Michael KlaykoDirectorBuy3,500$14.41$50,435.00View SEC Filing  
3/13/2014Deborah SnowSVPSell14,740$18.75$276,375.00View SEC Filing  
11/21/2013Deborah SnowSVPSell2,400$14.70$35,280.00View SEC Filing  
9/9/2013Clifford B MeltzerEVPSell35,000$14.56$509,600.00View SEC Filing  
8/15/2013Michael KlaykoDirectorBuy10,000$14.80$148,000.00View SEC Filing  
5/30/2013Deborah SnowSVPSell1,495$13.71$20,496.45View SEC Filing  
5/20/2013Stuart L BascombDirectorBuy3,701$14.02$51,888.02View SEC Filing  
5/15/2013Paul BlackCEOBuy7,120$14.02$99,822.40View SEC Filing  
5/14/2013Steve ShuteVPSell14,612$14.10$206,029.20View SEC Filing  
3/12/2013Paul BlackCEOBuy23,625$12.69$299,801.25View SEC Filing  
3/12/2013Stuart L BascombDirectorBuy10,000$12.64$126,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Allscripts Healthcare Solutions (NASDAQ MDRX) News Headlines

Source:
DateHeadline
Stocks To Watch: Allscripts Healthcare Solutions Sees RS Rating Jump To 81Stocks To Watch: Allscripts Healthcare Solutions Sees RS Rating Jump To 81
finance.yahoo.com - December 11 at 5:24 PM
What Investors Should Know About Allscripts Healthcare Solutions Inc’s (MDRX) Financial StrengthWhat Investors Should Know About Allscripts Healthcare Solutions Inc’s (MDRX) Financial Strength
finance.yahoo.com - December 11 at 10:23 AM
Allscripts Healthcare Solutions Inc (MDRX) Given Consensus Rating of "Hold" by BrokeragesAllscripts Healthcare Solutions Inc (MDRX) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - December 8 at 9:36 PM
Allscripts hits record-breaking 1 billion API data shares in a single year - GlobeNewswire (press release)Allscripts hits record-breaking 1 billion API data shares in a single year - GlobeNewswire (press release)
globenewswire.com - December 8 at 9:39 AM
Earnings Visibility Hamper Allscripts Healthcare Solutions (MDRX) Rating - Investorplace.comEarnings Visibility Hamper Allscripts Healthcare Solutions (MDRX) Rating - Investorplace.com
investorplace.com - December 8 at 9:39 AM
Allscripts hits record-breaking 1 billion API data shares in a single yearAllscripts hits record-breaking 1 billion API data shares in a single year
finance.yahoo.com - December 8 at 9:39 AM
Insider Selling: Allscripts Healthcare Solutions Inc (MDRX) SVP Sells 36,796 Shares of StockInsider Selling: Allscripts Healthcare Solutions Inc (MDRX) SVP Sells 36,796 Shares of Stock
www.americanbankingnews.com - December 4 at 6:12 PM
Allscripts to attend upcoming investor eventsAllscripts to attend upcoming investor events
finance.yahoo.com - December 4 at 5:10 PM
Traders Purchase Large Volume of Put Options on Allscripts Healthcare Solutions (MDRX)Traders Purchase Large Volume of Put Options on Allscripts Healthcare Solutions (MDRX)
www.americanbankingnews.com - November 27 at 2:52 AM
Quant Score Metrics Restrict Allscripts Healthcare Solutions (MDRX) Ratings Upgrade to Hold - Investorplace.comQuant Score Metrics Restrict Allscripts Healthcare Solutions (MDRX) Ratings Upgrade to Hold - Investorplace.com
investorplace.com - November 26 at 9:35 AM
Quant Score Metrics Restrict Allscripts Healthcare Solutions (MDRX) Ratings Upgrade to HoldQuant Score Metrics Restrict Allscripts Healthcare Solutions (MDRX) Ratings Upgrade to Hold
investorplace.com - November 23 at 1:33 PM
Allscripts Healthcare Solutions, Inc. breached its 50 day moving average in a Bullish Manner : MDRX-US : November 22, 2017Allscripts Healthcare Solutions, Inc. breached its 50 day moving average in a Bullish Manner : MDRX-US : November 22, 2017
finance.yahoo.com - November 23 at 6:24 AM
Q3 2018 EPS Estimates for Allscripts Healthcare Solutions, Inc. (MDRX) Boosted by AnalystQ3 2018 EPS Estimates for Allscripts Healthcare Solutions, Inc. (MDRX) Boosted by Analyst
www.americanbankingnews.com - November 22 at 12:50 PM
Allscripts Healthcare Solutions, Inc. (MDRX) Expected to Announce Quarterly Sales of $523.59 MillionAllscripts Healthcare Solutions, Inc. (MDRX) Expected to Announce Quarterly Sales of $523.59 Million
www.americanbankingnews.com - November 19 at 2:28 PM
Falling Earnings Visibility Keep Allscripts Healthcare Solutions (MDRX) a Sell - Investorplace.comFalling Earnings Visibility Keep Allscripts Healthcare Solutions (MDRX) a Sell - Investorplace.com
investorplace.com - November 17 at 8:59 PM
Allscripts to deliver anaesthesiology solution at the Royal Adelaide HospitalAllscripts to deliver anaesthesiology solution at the Royal Adelaide Hospital
finance.yahoo.com - November 17 at 3:56 PM
Allscripts to deliver anesthesiology solution at the Royal Adelaide HospitalAllscripts to deliver anesthesiology solution at the Royal Adelaide Hospital
finance.yahoo.com - November 17 at 3:56 PM
$0.18 Earnings Per Share Expected for Allscripts Healthcare Solutions, Inc. (MDRX) This Quarter$0.18 Earnings Per Share Expected for Allscripts Healthcare Solutions, Inc. (MDRX) This Quarter
www.americanbankingnews.com - November 17 at 9:18 AM
Falling Earnings Visibility Keep Allscripts Healthcare Solutions (MDRX) a SellFalling Earnings Visibility Keep Allscripts Healthcare Solutions (MDRX) a Sell
investorplace.com - November 16 at 1:41 PM
Allscripts Healthcare Solutions, Inc. (MDRX) Given Average Rating of "Hold" by AnalystsAllscripts Healthcare Solutions, Inc. (MDRX) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - November 13 at 9:34 PM
Allscripts Healthcare Solutions, Inc. (MDRX) Short Interest UpdateAllscripts Healthcare Solutions, Inc. (MDRX) Short Interest Update
www.americanbankingnews.com - November 13 at 2:34 AM
Quant Score Analytics Keep Allscripts Healthcare Solutions (MDRX) Ratings Upgrade to HoldQuant Score Analytics Keep Allscripts Healthcare Solutions (MDRX) Ratings Upgrade to Hold
investorplace.com - November 9 at 5:00 PM
ETFs with exposure to Allscripts Healthcare Solutions, Inc. : November 8, 2017ETFs with exposure to Allscripts Healthcare Solutions, Inc. : November 8, 2017
finance.yahoo.com - November 8 at 10:41 PM
Allscripts Healthcare Solutions, Inc. (MDRX) Lowered to Hold at Zacks Investment ResearchAllscripts Healthcare Solutions, Inc. (MDRX) Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - November 8 at 5:45 PM
Allscripts Healthcare Solutions, Inc. breached its 50 day moving average in a Bullish Manner : MDRX-US : November 8, 2017Allscripts Healthcare Solutions, Inc. breached its 50 day moving average in a Bullish Manner : MDRX-US : November 8, 2017
finance.yahoo.com - November 8 at 5:39 PM
Allscripts Healthcare Solutions, Inc. (MDRX) Lifted to Buy at Zacks Investment ResearchAllscripts Healthcare Solutions, Inc. (MDRX) Lifted to Buy at Zacks Investment Research
www.americanbankingnews.com - November 7 at 3:16 PM
Technical Reports on Application Software Equities -- Allscripts Healthcare Solutions, MobileIron, Nuance ... - PR Newswire (press release)Technical Reports on Application Software Equities -- Allscripts Healthcare Solutions, MobileIron, Nuance ... - PR Newswire (press release)
www.prnewswire.com - November 7 at 6:42 AM
Allscripts (MDRX) Q3 Earnings Meet, Revenues Beat Estimates - NasdaqAllscripts (MDRX) Q3 Earnings Meet, Revenues Beat Estimates - Nasdaq
www.nasdaq.com - November 5 at 8:22 PM
Allscripts Healthcare Solutions, Inc. (MDRX) Price Target Raised to $17.00Allscripts Healthcare Solutions, Inc. (MDRX) Price Target Raised to $17.00
www.americanbankingnews.com - November 5 at 9:40 AM
Allscripts Healthcare Solutions, Inc. (MDRX) Receives Buy Rating from Maxim GroupAllscripts Healthcare Solutions, Inc. (MDRX) Receives Buy Rating from Maxim Group
www.americanbankingnews.com - November 4 at 10:50 PM
Allscripts Healthcare Solutions, Inc. (MDRX) Receives Buy Rating from SunTrust Banks, Inc.Allscripts Healthcare Solutions, Inc. (MDRX) Receives Buy Rating from SunTrust Banks, Inc.
www.americanbankingnews.com - November 4 at 10:12 AM
Allscripts Healthcare Solutions (MDRX) Q3 2017 Results - Earnings Call TranscriptAllscripts Healthcare Solutions (MDRX) Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 3 at 5:00 PM
Allscripts Healthcare Solutions, Inc. to Host Earnings CallAllscripts Healthcare Solutions, Inc. to Host Earnings Call
finance.yahoo.com - November 3 at 5:00 PM
Allscripts announces third quarter 2017 resultsAllscripts announces third quarter 2017 results
finance.yahoo.com - November 3 at 5:00 PM
AllScripts reports 3Q lossAllScripts reports 3Q loss
finance.yahoo.com - November 3 at 5:00 PM
Edited Transcript of MDRX earnings conference call or presentation 2-Nov-17 8:30pm GMTEdited Transcript of MDRX earnings conference call or presentation 2-Nov-17 8:30pm GMT
finance.yahoo.com - November 3 at 5:00 PM
Analysis of Earnings Growth Makes Allscripts Healthcare Solutions (MDRX) a SellAnalysis of Earnings Growth Makes Allscripts Healthcare Solutions (MDRX) a Sell
investorplace.com - November 2 at 2:22 PM
Allscripts Healthcare Solutions Enters Oversold Territory - NasdaqAllscripts Healthcare Solutions Enters Oversold Territory - Nasdaq
www.nasdaq.com - November 2 at 6:19 AM
Allscripts Healthcare Solutions, Inc. – Value Analysis (NASDAQ:MDRX) : October 30, 2017Allscripts Healthcare Solutions, Inc. – Value Analysis (NASDAQ:MDRX) : October 30, 2017
finance.yahoo.com - October 31 at 3:41 AM
Zacks: Brokerages Anticipate Allscripts Healthcare Solutions, Inc. (MDRX) Will Announce Quarterly Sales of $429.94 MillionZacks: Brokerages Anticipate Allscripts Healthcare Solutions, Inc. (MDRX) Will Announce Quarterly Sales of $429.94 Million
www.americanbankingnews.com - October 30 at 12:36 PM
Allscripts Healthcare Solutions, Inc. breached its 50 day moving average in a Bearish Manner : MDRX-US : October 27, 2017Allscripts Healthcare Solutions, Inc. breached its 50 day moving average in a Bearish Manner : MDRX-US : October 27, 2017
finance.yahoo.com - October 28 at 8:03 AM
Equities Analysts Issue Forecasts for Allscripts Healthcare Solutions, Inc.s Q1 2018 Earnings (MDRX)Equities Analysts Issue Forecasts for Allscripts Healthcare Solutions, Inc.'s Q1 2018 Earnings (MDRX)
www.americanbankingnews.com - October 27 at 2:38 PM
First Week of June 2018 Options Trading For Allscripts Healthcare Solutions (MDRX)First Week of June 2018 Options Trading For Allscripts Healthcare Solutions (MDRX)
www.nasdaq.com - October 27 at 6:49 AM
ETFs with exposure to Allscripts Healthcare Solutions, Inc. : October 25, 2017ETFs with exposure to Allscripts Healthcare Solutions, Inc. : October 25, 2017
finance.yahoo.com - October 27 at 6:49 AM
Allscripts Healthcare Solutions, Inc. (MDRX) Short Interest Down 11.8% in OctoberAllscripts Healthcare Solutions, Inc. (MDRX) Short Interest Down 11.8% in October
www.americanbankingnews.com - October 27 at 1:26 AM
Earnings Growth Keeps Allscripts Healthcare Solutions (MDRX) a SellEarnings Growth Keeps Allscripts Healthcare Solutions (MDRX) a Sell
investorplace.com - October 26 at 2:06 PM
Allscripts Healthcare Solutions, Inc. (MDRX) to Release Quarterly Earnings on WednesdayAllscripts Healthcare Solutions, Inc. (MDRX) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - October 25 at 6:30 AM
Analysis of Earnings Visibility Keeps Allscripts Healthcare Solutions (MDRX) a Sell - Investorplace.comAnalysis of Earnings Visibility Keeps Allscripts Healthcare Solutions (MDRX) a Sell - Investorplace.com
investorplace.com - October 20 at 6:11 AM
Allscripts Healthcare Solutions, Inc. (MDRX) Given Consensus Recommendation of "Hold" by BrokeragesAllscripts Healthcare Solutions, Inc. (MDRX) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - October 19 at 8:46 PM
Analysis of Earnings Visibility Keeps Allscripts Healthcare Solutions (MDRX) a SellAnalysis of Earnings Visibility Keeps Allscripts Healthcare Solutions (MDRX) a Sell
investorplace.com - October 19 at 2:06 PM

SEC Filings

Allscripts Healthcare Solutions (NASDAQ:MDRX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Allscripts Healthcare Solutions (NASDAQ:MDRX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Allscripts Healthcare Solutions (NASDAQ MDRX) Stock Chart for Saturday, December, 16, 2017

Loading chart…

This page was last updated on 12/16/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.